Sven Hauke
Bremerhaven, HB, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Journal: Breast cancer research and treatment
Published: March 12, 2020
HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category.
Journal: Histopathology
Published: February 10, 2017
The FlexISH assay brings flexibility to cytogenetic HER2 testing.
Journal: Histopathology
Published: November 09, 2015
BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.
Journal: Oncology letters
Published: March 23, 2015
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.
Journal: Histopathology
Published: April 27, 2014
Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
Journal: European urology
Published: November 25, 2013
Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026